- News Home
10 April 2014 11:44 am ,
Vol. 344 ,
The Pyrenean ibex, an impressive mountain goat that lived in the central Pyrenees in Spain, went extinct in 2000. But a...
Tight budgets are forcing NASA to consider turning off one or more planetary science projects that have completed their...
Ebola is not a stranger to West Africa—an outbreak in the 1990s killed chimpanzees and sickened one researcher. But the...
In an as-yet-unpublished report, an international panel of geoscientists has concluded that a pair of deadly...
Tropical disease experts tried and failed before to eradicate yaws, a rare disfiguring disease of poor countries. Now,...
Since 2002, researchers have reported that agricultural communities in the hot and humid Pacific Coast of Central...
Balkan endemic kidney disease surfaced in the 1950s and for decades defied attempts to finger the cause. It occurred...
- 10 April 2014 11:44 am , Vol. 344 , #6180
- About Us
U.S. Stem Cell Trial Treats First Patient
12 October 2010 11:14 am
The first approved U.S. clinical trial to use human embryonic stem cells to treat a disease has enrolled its first patient. Geron Corp., which is sponsoring the trial using stem cells for spinal cord injury, announced yesterday that the patient was treated at a hospital in Atlanta. Patients in the study will receive an injection of stem cells at the site of spinal cord damage within 2 weeks after the injury. The small trial is a safety study, but as The Washington Post notes, researchers will also test to see if they benefit from the therapy. The U.S. Food and Drug Administration approved the trial in January 2009 but later suspended it because of safety concerns; FDA lifted the hold in July.